TITLE

Molecular Research in Urology 2014: Update on PET/MR Imaging of the Prostate

AUTHOR(S)
Wetter, Axel
PUB. DATE
August 2014
SOURCE
International Journal of Molecular Sciences;Aug2014, Vol. 15 Issue 8, p13401
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article gives an overview of recent publications and potential indications of Positron emission tomography/ Magnetic resonance (PET/MR) imaging of prostate cancer.
ACCESSION #
97755658

 

Related Articles

  • Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer. Afshar-Oromieh, Ali; Zechmann, Christian M.; Malcher, Anna; Eder, Matthias; Eisenhut, Michael; Linhart, Heinz G.; Holland-Letz, Tim; Hadaschik, Boris A.; Giesel, Frederik L.; Debus, Jürgen; Haberkorn, Uwe // European Journal of Nuclear Medicine & Molecular Imaging;Jan2014, Vol. 41 Issue 1, p11 

    Purpose: Positron emission tomography (PET) with choline tracers has found widespread use for the diagnosis of prostate cancer (PC). However, choline metabolism is not increased in a considerable number of cases, whereas prostate-specific membrane antigen (PSMA) is overexpressed in most PCs....

  • Integrated 68Gallium Labelled Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Magnetic Resonance Imaging Enhances Discriminatory Power of Multi-Parametric Prostate Magnetic Resonance Imaging. Al-Bayati, Mohammad; Grueneisen, Johannes; Lütje, Susanne; Sawicki, Lino M.; Suntharalingam, Saravanabavaan; Tschirdewahn, Stephan; Forsting, Michael; Rübben, Herbert; Herrmann, Ken; Umutlu, Lale; Wetter, Axel // Urologia Internationalis;Feb2018, Vol. 100 Issue 2, p164 

    Purpose: To evaluate diagnostic accuracy of integrated 68Gallium labelled prostate-specific membrane antigen (68Ga-PSMA)-11 positron emission tomography (PET)/MRI in patients with primary prostate cancer (PCa) as compared to multi-parametric MRI....

  • False-negative Bone Scan and Choline PET/CT Study in a Case of Prostate Cancer: The Pitfall of the Small Cell Prostate Carcinoma Variant. Al-Tamimi, Ammad; Tan, Andrew Eik Hock; Kwong, Sidney Yu Wing; Sam, Christopher Cheng Wai; Chong, Angela; Cher Heng Tan // World Journal of Nuclear Medicine;May2012, Vol. 11 Issue 2, p75 

    We present a rare variant of prostate carcinoma. The patient is a 45-year-old male with elevated prostate-specific antigen levels at screening. Magnetic resonance imaging revealed hyperenhancing lesions throughout the axial skeleton. The fluorine-18 fluorocholine (FCH) positron emission...

  • Ga-PSMA PET/MR with multimodality image analysis for primary prostate cancer. Eiber, Matthias; Nekolla, Stephan; Maurer, Tobias; Weirich, Gregor; Wester, Hans-Jürgen; Schwaiger, Markus // Abdominal Imaging;Aug2015, Vol. 40 Issue 6, p1769 

    Current imaging procedures for prostate cancer including positron emission tomography (PET) exhibit considerable limitations and are not always able to meet the diagnostic needs. Recently, a Gallium-labeled ligand of the prostate-specific membrane antigen (Ga-PSMA) has been introduced in...

  • Initial Evaluation of [F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer. Szabo, Zsolt; Mena, Esther; Rowe, Steven; Plyku, Donika; Nidal, Rosa; Eisenberger, Mario; Antonarakis, Emmanuel; Fan, Hong; Dannals, Robert; Chen, Ying; Mease, Ronnie; Vranesic, Melin; Bhatnagar, Akrita; Sgouros, George; Cho, Steve; Pomper, Martin // Molecular Imaging & Biology;Aug2015, Vol. 17 Issue 4, p565 

    Purpose: Prostate-specific membrane antigen (PSMA) is a recognized target for imaging prostate cancer. Here we present initial safety, biodistribution, and radiation dosimetry results with [F]DCFPyL, a second-generation fluorine-18-labeled small-molecule PSMA inhibitor, in patients with prostate...

  • Modalities for imaging of prostate cancer. Hou, A. H.; Swanson, D.; Barqawi, A. B. // Advances in Urology;2009, Special section p1 

    Prostate cancer is the second most common cause of cancer deaths among males in the United States. Prostate screening by digital rectal examination and prostate-specific antigen has shifted the diagnosis of prostate cancer to lower grade, organ confined disease, adding to overdetection and...

  • MRI and prostate cancer: the next frontier. Klotz, Laurence H. // Canadian Urological Association Journal;Aug2010, Vol. 4 Issue 4, p227 

    The author discusses the treatment of the patients with prostate cancer by transrectal ultrasound (TRUS). He states that improvements and accuracy in the TRUS technology is growing at a good rate and the results of TRUS are not generally incorporated into treatment decisions. Due to this many...

  • Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary results. Akin, Oguz; Gultekin, David H.; Vargas, Hebert Alberto; Zheng, Junting; Moskowitz, Chaya; Xin Pei; Sperling, Dahlia; Schwartz, Lawrence W.; Hricak, Hedvig; Zelefsky, Michael J. // European Radiology;Sep2011, Vol. 21 Issue 9, p1970 

    Objectives: To assess the incremental value of diffusion-weighted (DW-MRI) and dynamic contrast-enhanced MRI (DCE-MRI) to T2-weighted MRI (T2WI) in detecting locally recurrent prostate cancer after radiotherapy. Methods: Twenty-four patients (median age, 70 years) with a history of...

  • Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging. Panebianco, Valeria; Barchetti, Flavio; Sciarra, Alessandro; Musio, Daniela; Forte, Valerio; Gentile, Vincenzo; Tombolini, Vincenzo; Catalano, Carlo // European Radiology;Jun2013, Vol. 23 Issue 6, p1745 

    Objectives: To validate the role of 3-T diffusion-weighted imaging (DWI) in the detection of local prostate cancer recurrence after radical prostatectomy (RP). Methods: T2-weighted imaging, DWI and dynamic contrast-enhanced MRI (DCE-MRI) were performed with a 3-T magnet in 262 patients after RP....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics